Immune checkpoint inhibitor toxicity and associated outcomes in a geriatric population.

被引：0
|
作者：
Polewski, Peter James
Hayashi-Tanner, Yacki
Gaddam, Mamatha
Fisher, Nancy R.
Kovacs, Attila J.
Marinier, David E.
机构：
[1] Gundersen Hlth Syst, La Crosse, WI USA
[2] Gundersen H, La Crosse, WI USA
[3] Gunderson Med Fdn, La Crosse, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24014
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitor Therapy Associated Hypophysitis
    Mahzari, Moeber
    Liu, Dora
    Arnaout, Amel
    Lochnan, Heather
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2015, 8 : 21 - 28
  • [42] Endocrinopathies Associated With Immune Checkpoint Inhibitor Use
    Kotwal, Anupam
    Kennedy, Randol
    Kikani, Nupur
    Thosani, Sonali
    Goldner, Whitney
    Shariff, Afreen
    ENDOCRINE PRACTICE, 2024, 30 (06) : 584 - 591
  • [43] IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOPATHY
    Pavia Pascual, M.
    De La Torre Rubio, N.
    Machattou, M.
    Navarro Palomo, P.
    Navarro Joven, C.
    Alonso de Francisco, M.
    Barbadillo Mateos, C.
    Merino Argumanez, C.
    Godoy, H.
    Fernandez Castro, M.
    Garcia-Magallon, B.
    Sanz, J.
    De Villa, L. F.
    Andreu Sanchez, J. L.
    Campos Esteban, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1647 - 1648
  • [44] Neurotoxicities associated with immune checkpoint inhibitor therapy
    Sophie L. Duong
    Frank J. Barbiero
    Richard J. Nowak
    Joachim M. Baehring
    Journal of Neuro-Oncology, 2021, 152 : 265 - 277
  • [45] Neurotoxicities Associated with Immune Checkpoint Inhibitor Therapy
    Duong, Sophie L.
    Barbiero, Frank J.
    Nowak, Richard J.
    Baehring, Joachim M.
    ANNALS OF NEUROLOGY, 2018, 84 : S138 - S138
  • [46] IMMUNE CHECKPOINT INHIBITOR RESUMPTION IS ASSOCIATED WITH BETTER LONG TERM OUTCOMES IN CANCER PATIENTS
    Zou, Fangwen
    Thomas, Anusha Shirwaikar
    Dutra, Barbara E.
    Khurana, Shruti
    Oliva, Isabella C. Glitza
    Thompson, John A.
    Wang, Yinghong
    GASTROENTEROLOGY, 2021, 160 (06) : S337 - S337
  • [47] Antibiotic exposure for immune checkpoint inhibitor induced bullous pemphigoid associated with worse outcomes
    Fay, C. J.
    Awh, K.
    Said, J. T.
    Allais, B. S.
    LeBoeuf, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S95 - S95
  • [48] Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study
    Cortazar, Frank B.
    Kibbelaar, Zoe A.
    Glezerman, Ilya G.
    Abudayyeh, Ala
    Mamlouk, Omar
    Motwani, Shveta S.
    Murakami, Naoka
    Herrmann, Sandra M.
    Manohar, Sandhya
    Shirali, Anushree C.
    Kitchlu, Abhijat
    Shirazian, Shayan
    Assal, Amer
    Vijayan, Anitha
    Renaghan, Amanda DeMauro
    Ortiz-Melo, David, I
    Rangarajan, Sunil
    Malik, A. Bilal
    Hogan, Jonathan J.
    Dinh, Alex R.
    Shin, Daniel Sanghoon
    Marrone, Kristen A.
    Mithani, Zain
    Johnson, Douglas B.
    Hosseini, Afrooz
    Uprety, Deekchha
    Sharma, Shreyak
    Gupta, Shruti
    Reynolds, Kerry L.
    Sise, Meghan E.
    Leaf, David E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (02): : 435 - 446
  • [49] Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy
    Ozaki, Aya F.
    Sayer, Michael
    Hamano, Hirofumi
    Nagasaka, Misako
    Lee, Benjamin J.
    Doh, Jean
    Naqvi, Ali
    Nowrouzi, Nareh
    Zamami, Yoshito
    Patel, Pranav M.
    CARDIO-ONCOLOGY, 2025, 11 (01)
  • [50] Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review
    Sise, Meghan E.
    Seethapathy, Harish
    Reynolds, Kerry L.
    ONCOLOGIST, 2019, 24 (06): : 735 - 742
12345